Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses (2017)
- Authors:
- USP affiliated authors: HONORIO, KÁTHIA MARIA - EACH ; WRENGER, CARSTEN - ICB ; TROSSINI, GUSTAVO HENRIQUE GOULART - FCF
- Unidades: EACH; ICB; FCF
- DOI: 10.4155/fmc-2016-0179
- Subjects: STAPHYLOCOCCUS; RELAÇÕES QUANTITATIVAS ENTRE ESTRUTURA QUÍMICA E ATIVIDADE BIOLÓGICA; MODELAGEM MOLECULAR
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Future Medicinal Chemistry
- ISSN: 1756-8919
- Volume/Número/Paginação/Ano: v. 9, n. 2, p. 135-151, feb. 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
KRONENBERGER, Thales et al. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, v. 9, n. 2, p. 135-151, 2017Tradução . . Disponível em: https://doi.org/10.4155/fmc-2016-0179. Acesso em: 23 maio 2024. -
APA
Kronenberger, T., Asse Junior, L. R., Wrenger, C., Trossini, G. H. G., Honorio, K. M., & Maltarollo, V. G. (2017). Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses. Future Medicinal Chemistry, 9( 2), 135-151. doi:10.4155/fmc-2016-0179 -
NLM
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2024 maio 23 ] Available from: https://doi.org/10.4155/fmc-2016-0179 -
Vancouver
Kronenberger T, Asse Junior LR, Wrenger C, Trossini GHG, Honorio KM, Maltarollo VG. Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure–activity relationship analyses [Internet]. Future Medicinal Chemistry. 2017 ; 9( 2): 135-151.[citado 2024 maio 23 ] Available from: https://doi.org/10.4155/fmc-2016-0179 - Advances and challenges in drug design of PPARδ ligands
- Simulação do espectro de absorção UV do filtro solar p-metoxicinamato de etilexila empregando métodos teóricos (TD-DFT)
- Use of machine learning approaches for novel drug discovery
- Current trends in quantitative structure-activity relationship validation and applications on drug discovery
- On the relationship of anthranilic derivatives structure and the FXR (Farnesoid X receptor) agonist activity
- Understanding PPAR-δ affinity and selectivity using hologram quantitative structure–activity modeling, molecular docking and GRID calculations
- The role of QSAR and virtual screening studies in type 2 diabetes drug discovery
- In silico studies on the interaction between bioactive ligands and ALK5, a biological target related to the cancer treatment
- Benchmark studies of UV-vis spectra simulation for cinnamates with UV filter profile
- Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum
Informações sobre o DOI: 10.4155/fmc-2016-0179 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
